)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
Plus Therapeutics
Plus Therapeutics (PSTV) investor relations material
Plus Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary31 Mar, 2026
Voting matters and shareholder proposals
Election of six directors for a one-year term, with nominees listed for shareholder approval.
Ratification of CBIZ P.C. as the independent registered public accounting firm for the 2026 fiscal year.
Advisory vote on executive compensation for named executive officers.
Approval of the Sixth Amendment and Restatement of the 2020 Stock Incentive Plan.
Additional business may be transacted as properly brought before the meeting.
Board of directors and corporate governance
Six director nominees are presented for election, each to serve until the 2027 annual meeting or until a successor is elected.
Executive compensation and say-on-pay
Shareholders are asked to provide a non-binding advisory vote on the compensation of named executive officers.
Proposal includes approval of amendments to the 2020 Stock Incentive Plan.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Plus Therapeutics
- Board seeks approval for director elections, auditor ratification, and expanded equity plan.PSTV
Proxy filing31 Mar 2026 - Expanded CNSide coverage and REYOBIQ clinical progress drove 2025, with a $22.4M net loss.PSTVQ4 202513 Mar 2026
- Positive clinical data, new grants, and CNSide launch offset by financial and regulatory risks.PSTVQ2 20241 Feb 2026
- $15M raise funds clinical trials, CNSide growth, and 2026 expansion with strong payor coverage.PSTVBusiness update22 Jan 2026
- Promising CNS radiotherapeutic programs advance toward pivotal trials and commercial diagnostics.PSTVH.C. Wainwright 26th Annual Global Investment Conference 202421 Jan 2026
- Clinical progress and new financing support growth, but liquidity and compliance risks remain.PSTVQ3 202414 Jan 2026
- IPO seeks to fund CNS cancer radiotherapeutics and diagnostics amid ongoing financial risk.PSTVRegistration Filing9 Jan 2026
- $15M raised, CNSide launch in 2025, and improved net loss per share for 2024.PSTVQ4 202426 Dec 2025
- Over 1.5B shares registered for resale; proceeds from warrant exercises may fund oncology innovation.PSTVRegistration Filing16 Dec 2025
Next Plus Therapeutics earnings date
Q1 202630 Apr, 2026
Plus Therapeutics
Next Plus Therapeutics earnings date
Q1 202630 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage